RM Jr. Strain-specific suppression of microRNA-320 by carcinogenic Helicobacter pylori promotes expression of the antiapoptotic protein Mcl-1. Am J Physiol Gastrointest Liver Physiol 305: G786 -G796, 2013. First published October 17, 2013 doi:10.1152/ajpgi.00279.2013Helicobacter pylori is the strongest risk factor for gastric cancer, and strains harboring the cag pathogenicity island, which translocates the oncoprotein CagA into host cells, further augment cancer risk. We previously reported that in vivo adaptation of a noncarcinogenic H. pylori strain (B128) generated a derivative strain (7.13) with the ability to induce adenocarcinoma, providing a unique opportunity to define mechanisms that mediate gastric carcinogenesis. MicroRNAs (miRNAs) are small noncoding RNAs that regulate expression of oncogenes or tumor suppressors and are frequently dysregulated in carcinogenesis. To identify miRNAs and their targets involved in H. pylori-mediated carcinogenesis, miRNA microarrays were performed on RNA isolated from gastric epithelial cells cocultured with H. pylori strains B128, 7.13, or a 7.13 cagA Ϫ isogenic mutant. Among 61 miRNAs differentially expressed in a cagA-dependent manner, the tumor suppressor miR-320 was significantly downregulated by strain 7.13. Since miR-320 negatively regulates the antiapoptotic protein Mcl-1, we demonstrated that H. pylori significantly induced Mcl-1 expression in a cagA-dependent manner and that suppression of Mcl-1 results in increased apoptosis. To extend these results, mice were challenged with H. pylori strain 7.13 or its cagA Ϫ mutant; consistent with cell culture data, H. pylori induced Mcl-1 expression in a cagA-dependent manner. In human subjects, cag ϩ strains induced significantly higher levels of Mcl-1 than cag Ϫ strains, and Mcl-1 expression levels paralleled the severity of neoplastic lesions. Collectively, these results indicate that H. pylori suppresses miR-320, upregulates Mcl-1, and decreases apoptosis in a cagAdependent manner, which likely confers an increased risk for gastric carcinogenesis.
the second leading cause of cancer-related death, with ϳ700,000 deaths/year attributable to this malignancy (28) . The primary initiating factor in the development of gastric cancer is chronic gastritis induced by the bacterial pathogen, Helicobacter pylori. H. pylori selectively colonizes the gastric epithelium of over 50% of the world's population and typically persists for the lifetime of its host. Chronic gastric inflammation induced by H. pylori persists for decades and significantly increases the risk of gastric adenocarcinoma (30) . Although H. pylori-induced gastritis is the strongest known risk factor for gastric cancer, only a fraction of colonized individuals ever develop neoplasia. Strain-specific bacterial virulence factors, host responses, and environmental constituents, either alone or in combination, contribute to enhanced cancer risk.
One bacterial factor that increases gastric cancer risk is the cag pathogenicity island (PAI). H. pylori strains that harbor the cag PAI induce more severe gastric injury and further augment the risk for developing gastric cancer compared with strains that lack this virulence constituent (30) . The cag island encodes a bacterial type IV secretion system (T4SS), which translocates CagA, the product of the terminal gene within the island, into host cells. Intracellular CagA can become phosphorylated by Src kinases (23, 38, 39) or remain unphosphorylated. In either form, CagA affects multiple pathways that alter host cell morphology, signaling, and inflammatory responses (2, 21, 26, 32, 35) . However, most persons infected by cag ϩ H. pylori strains never develop cancer. These observations underscore the importance of defining factors that may alone, or in tandem with known virulence determinants, increase risk for this malignancy.
Host factors that may contribute to gastric cancer risk include oncogenic or tumor suppressor microRNAs (miRNAs). miRNAs are small, noncoding RNAs ϳ20 -25 nucleotides in length that function as posttranscriptional regulators of gene expression (3) . miRNAs function by binding to the 3= untranslated region (3= UTR) of messenger RNAs (mRNAs), resulting in mRNA degradation and gene silencing or translational repression (3) . It is estimated that the human genome encodes thousands of miRNAs, targeting up to 60% of all proteincoding genes (14) . miRNAs are involved in many biological processes, including development, differentiation, angiogenesis, cell cycle progression, proliferation, apoptosis, and activa-tion of signal transduction pathways (1) . Dysregulation of miRNA expression with subsequent disruption of these processes can result in immune and inflammatory disorders (37, 43) as well as malignancy (16, 41) . Recent studies have demonstrated that H. pylori can modulate expression of miRNAs, which may contribute to disease (25) .
Animal models provide important insights into mechanisms that regulate gastric carcinogenesis. We previously identified a strain of H. pylori, 7.13, that reproducibly induces gastric cancer in two rodent models of gastritis, Mongolian gerbils and hypergastrinemic INS-GAS mice (11) . This strain was derived via in vivo adaptation of a clinical H. pylori strain, B128, which induces inflammation, but not cancer, in rodent gastric mucosa. H. pylori strains B128 and 7.13 are closely related genetically (10) but differ in oncogenic potential; therefore, we capitalized on this unique resource to identify specific microRNAs altered in gastric epithelial cells by a carcinogenic H. pylori strain.
MATERIALS AND METHODS
H. pylori strains and growth conditions. The H. pylori cag ϩ strains B128 (12), 7.13 (11) , and a 7.13 cagA Ϫ isogenic mutant strain were grown on trypticase soy agar-5% sheep blood plates (BD Biosciences, Franklin Lakes, NJ) at 37°C with 5% CO 2. The cagA Ϫ isogenic mutant was maintained under selection on Brucella agar (BD Biosciences) plates containing 20 g/ml kanamycin (Sigma-Aldrich, St. Louis, MO). H. pylori strains were then grown in Brucella broth with 10% fetal bovine serum (Atlanta Biologicals, Norcross, GA) for 18 h at 37°C with 5% CO 2 prior to experimentation.
Gastric epithelial cells and coculture conditions. MKN28 (human gastric epithelial cells isolated from a patient with gastric adenocarcinoma) and AGS (human gastric epithelial cells isolated from a 54-yr-old Caucasian female with gastric adenocarcinoma, ATCC, Manassas, VA) were grown in RPMI 1640 (Life Technologies, Carlsbad, CA) supplemented with 10% fetal bovine serum (Atlanta Biologicals), L-glutamine (2 mM, BD Biosciences, Franklin Lakes, NJ), and HEPES buffer (1 mM, Cellgro, Manassas, VA) at 37°C with 5% CO2. H. pylori strains were cocultured with gastric epithelial cells at a multiplicity of infection (MOI) of 100:1 for indicated time points.
RNA isolation and microRNA microarray analysis. Total RNA was isolated from MKN28 cells cocultured with or without H. pylori by use of the miRNeasy Mini Kit (Qiagen, Venlo, Limburg, the Netherlands) and small RNAs were isolated by use of the mirVana miRNA Isolation Kit (Ambion Life Technologies, Carlsbad, CA). Small RNAs were labeled with Cy5 at a 1:1 ratio. Unincorporated Cy5 was removed by use of a Nucleotide Removal Kit (Qiagen) and diluted to 2 mg per array. Synthetic lycopene synthase RNA was labeled and purified by the same protocol and was diluted to 50 pg per array. Hybridizations were performed in 25% deionized formamide, 5ϫ SCC, and 0.1% SDS, for 16 h in ArrayIt hybridization chambers followed by three washes in 2ϫ SCC 0.1% SDS, 1ϫ SCC, and 0.1ϫ SCC, as previously described (40) . All arrays were scanned with GenePix4000B scanner (Molecular Devices, Sunnyvale, CA) and data were analyzed using GeneSpring GX 10.0.2 software (Aligent Technologies, Santa Clara, CA). All experiments were performed in triplicate. For normalization, hybridizations were spiked with identical amounts of lycopene synthase RNA. Predicted mRNA targets were obtained using the prediction algorithms TargetScan and miRanda.
Northern blot analysis. Thirty micrograms of total RNA was separated on 12% urea-polyacrylamide gels and then transferred to positively charged membranes at 80 V for 1 h at 4°C. A miR-320 probe was radioactively labeled with ␣-32 P-ATP by use of a StarFire
Labeling Kit (Integrated DNA Technologies IDT, Coralville, IA) and added to the membrane. A U6 probe was radioactively labeled with ␥-32 P-ATP and used as a loading control. This reaction was left overnight at 37°C and unhybridized probe was removed with 2ϫ SSPE 0.1% SDS, 1ϫ SSPE 0.1% SDS, and 0.5ϫ SSPE 1% SDS, as previously described (40 Murine model of H. pylori infection. All animal studies were carried out in strict accordance with the recommendations in the Guide for the Care and Use of Laboratory Animals of the National Institutes of Health. Vanderbilt University Medical Center's Institutional Animal Care and Use Committee approved all protocols and all efforts were made to minimize animal suffering. Male hypergastrinemic FVB/N INS-GAS mice were bred and housed in the Vanderbilt University Animal Care Facilities in a room with a 12-h light-dark cycle at 21-22°C. Mice were orogastrically challenged with Brucella broth, as an uninfected control, with the rodent-adapted H. pylori strain 7.13, or a 7.13 cagA Ϫ isogenic mutant. Mice were euthanized at 12-24 wk postchallenge and gastric tissue was harvested.
To assess H. pylori-induced inflammation, linear strips of gastric tissue, extending from the squamocolumnar junction through the proximal duodenum, were fixed in 10% neutral-buffered formalin (Azer Scientific), paraffin embedded, and stained with hematoxylin and eosin. A single pathologist (M. B. Piazuelo), blinded to treatment groups, scored indices of inflammation. Severity of acute or chronic inflammation was graded on a scale of 0 to 3 in both the gastric antrum and corpus, leading to a maximum combined score of 12.
Immunohistochemistry. To assess Mcl-1 expression in murine gastric tissue, immunohistochemical (IHC) analysis was performed on deparaffinized gastric tissue sections by using a murine polyclonal anti-Mcl-1 antibody (1:3,000, Santa Cruz Biotechnologies). A single pathologist (M. B. Piazuelo), blinded to treatment groups, scored Fig. 1 . A carcinogenic Helicobacter pylori strain induces distinct microRNA expression profiles compared with its noncarcinogenic progenitor strain or an isogenic cagA Ϫ mutant and specifically downregulates miR-320 in a cagA-dependent manner. A: total RNA was isolated from uninfected (UI) MKN28 gastric epithelial cells, or MKN28 cells infected with H. pylori strains B128, 7.13, or a 7.13 cagA Ϫ isogenic mutant for 24 h. Small RNAs were isolated, fluorescently labeled, and hybridized to an array containing 346 unique miRNAs. Each line within a row indicates a unique miRNA. Blue color indicates background levels of expression, and red color indicates high levels of expression. B: Northern blot analyses were used to assess miR-320 expression levels relative to an endogenously expressed small RNA, U6. Error bars indicate standard error of the mean (SE) from experiments performed on at least 3 independent occasions. ANOVA tests were used to determine statistical significance among groups.
Mcl-1 epithelial staining in the entire length of the antral mucosa. The percentage of Mcl-1 ϩ staining epithelial cells was assessed semiquantitatively and the intensity of epithelial Mcl-1 staining was graded on a scale of 1-3 (weak, moderate, or strong), as previously reported (24) . The Mcl-1 epithelial score was determined by multiplying the Mcl-1 staining intensity by the percentage of positively stained cells.
Gastric biopsies from human subjects from the Andean mountain Nariño region of Colombia (18) (Fig. 1A ) (39) . Sixty-four miRNAs were significantly altered (Ͼ5-fold) between cells cocultured with strain B128 and strain 7.13 (data not shown). Similarly, 61 miRNAs were significantly altered (Ͼ5-fold) between cells cocultured with strain 7.13 vs. the cagA Ϫ isogenic mutant (Table 1) . Of interest, miR-320, which functions to regulate the expression of specific oncogenes, was downregulated in gastric epithelial cells following infection with carcinogenic strain 7.13 compared with both the parental strain B128 and the 7.13 cagA Ϫ mutant (Table 1) . To verify the microarray results, Northern blot analyses were performed to assess miR-320 expression levels in gastric epithelial cells. Consistent with the array data, strain 7.13 significantly decreased miR-320 expression compared with either strain B128 or the cagA Ϫ mutant (Fig. 1B) . These data indicate that a subset of miRNAs can be selectively altered by a carcinogenic H. pylori strain in a cagA-dependent manner.
H. pylori upregulates mcl-1 in a cagA-dependent manner, consistent with downregulation of miR-320. To identify potential miR-320 mRNA targets linked to oncogenesis, a variety of prediction algorithms were utilized. Myeloid cell leukemia-1 (Mcl-1), a member of the antiapoptotic Bcl-2 protein family, was the most highly predicted target of miR-320, as defined by the conservation and number of binding sites (N ϭ 5) within the 3= untranslated region (UTR) of mcl-1 mRNA (Fig. 2A) . Prior data have also demonstrated that miR-320 negatively regulates mcl-1 expression and facilitates the induction of apoptosis (6) .
To assess mcl-1 expression in our microbial-host epithelial interaction model system, gastric epithelial cells were cocultured with H. pylori strain 7.13 or its cagA Ϫ isogenic mutant and levels of mcl-1 mRNA were determined by quantitative real-time RT-PCR (Fig. 2B) . Consistent with the downregulation of miR-320, H. pylori strain 7.13 induced significantly increased levels of mcl-1 expression at 2, 4, 8, and 24 h postinfection compared with either uninfected control cells or cells infected with the cagA Ϫ isogenic mutant. To assess levels of Mcl-1 protein expression, Western blot analyses (Fig. 2, C  and D) were performed. Consistent with the mRNA expression (Fig. 3A) , Western blot (Fig. 3,  B and C) , and flow cytometry (Fig. 3D) analyses, respectively. These data demonstrated that Mcl-1-targeting siRNA results in an approximate 75% decrease in mcl-1 mRNA levels (Fig. 3A) and an 80% decrease in Mcl-1 protein levels (Fig. 3, B-D) .
Since Mcl-1 can function as a suppressor of apoptosis, we next evaluated this cellular response by flow cytometry. Consistent with previous reports (5, 17, 22) , infection of gastric epithelial cells with H. pylori resulted in a significant induction of apoptosis, as assessed by increased active caspase-3 expression levels, compared with uninfected, Lipofectamine controls. However, H. pylori-induced apoptosis was significantly increased in cells treated with Mcl-1-targeting siRNA, compared with either Lipofectamine and NT siRNA controls (Fig. 3E ). These data indicate that downregulation of miR-320 and subsequent upregulation of Mcl-1 by H. pylori may be one mechanism to suppress cellular apoptosis.
H. pylori induces inflammation and Mcl-1 expression in a cagA-dependent manner within murine gastric mucosa.
To extend our in vitro results into an in vivo model of carcinogenesis, male INS-GAS mice, which are hypergastrinemic and at heightened risk for developing gastric cancer (15) , were challenged with Brucella broth as a negative control, wild-type carcinogenic H. pylori strain 7.13, or a 7.13 cagA Ϫ isogenic mutant for 12-24 wk (Fig. 4A) . Colonization efficiency was 100% following challenge with wild-type strain 7.13 or its cagA Ϫ isogenic mutant. Because of the persistent hypergastrinemia in this model, uninfected mice are susceptible to the development of gastritis. Despite low levels of gastric inflammation in uninfected INS-GAS mice, infection with wild-type strain 7.13 resulted in a significant and robust inflammatory response compared with uninfected controls or infection with the cagA Ϫ isogenic mutant, indicating that H. pylori-induced inflammation occurs in a cagA-dependent manner in this model (Fig. 4B) .
To assess expression of Mcl-1 in this model, immunohistochemistry was performed. Consistent with the in vitro results (Fig. 2) , infection with wild-type strain 7.13 resulted in a significant increase in Mcl-1 immunostaining throughout the gastric mucosa, whereas only minimal Mcl-1 immunostaining was observed in uninfected mice or mice infected with the cagA Ϫ mutant, indicating that H. pylori-induced Mcl-1 expression occurs in a cagA-dependent manner in vivo (Fig.  4, C and D) . To define the relationship between H. pyloriinduced inflammation and Mcl-1 expression, gastritis scores and Mcl-1 epithelial staining were compared via linear regression analysis. There was a significant correlation between the severity of gastric inflammation and expression of Mcl-1 (Fig. 4E) (Fig. 5, A-D) .
Mcl-1 expression increases in parallel to gastric neoplastic progression in humans. To further evaluate the role of Mcl-1 in neoplastic transformation of the stomach, Mcl-1 expression was assessed by immunohistochemistry in uninfected individuals with normal gastric mucosa and H. pyloriinfected subjects diagnosed with nonatrophic gastritis, intestinal metaplasia, or adenocarcinoma. Expression of Mcl-1 paralleled the severity of gastric preneoplastic lesions (Fig. 6, A-D) . Following quantification of epithelial staining and intensity, Mcl-1 epithelial expression levels progressively increased at each stage of neoplastic progression, providing further evidence that altered expression of Mcl-1 by H. pylori cag ϩ strains may play a role in gastric carcinogenesis.
DISCUSSION
Gastric adenocarcinoma is the second leading cause of cancerrelated death in the world, and H. pylori infection is the strongest known risk factor for this malignancy (30) . We have now shown that carcinogenic strains of H. pylori significantly alter host miRNA expression profiles that may affect cellular responses involved in carcinogenesis. Previous studies have assessed miRNA expression profiles in response to H. pylori infection as well as in gastric cancer specimens, as reviewed in Ref. 25 . Although the majority of miRNAs that were altered in response to H. pylori infection in this study were novel, alteration of miR-17, miR-34b, miR-34c, and miR-320 were consistent with previous reports. Furthermore, miR -17, miR-19, miR34b, miR-34c, miR-126, miR-128, miR-139 , and miR-185 expression changes in response to H. pylori infection were consistent with expression patterns previously observed in gastric cancer specimens (25) . We prioritized identified miRNAs based on the oncogenic potential of their corresponding targets and miR-320 was specifically investigated in greater depth based on its ability to regulate the antiapoptotic protein Mcl-1. miR-320 was significantly downregulated by carcinogenic H. pylori in a cagA-dependent manner. miR-320 has been previously shown to be decreased in specimens from breast cancer (45), intrahepatic cholangiocarcinoma (6), prostate cancer (13), colon cancer (34) , and acute myelogenous leukemia (33) , suggesting that miR-320 may act as a tumor suppressor during cancer progression. Although miR-320 likely exhibits a wide range of tumor suppressor activities, it has been demonstrated to negatively regulate Mcl-1 and attenuate apoptosis (6) .
Mcl-1 is a member of the Bcl-2 protein family. The rapid induction and degradation of Mcl-1 suggests it plays an important role in apoptotic control in response to rapidly changing environmental cues (7) . Mcl-1 is one of the most highly amplified genes in human cancers, including hematopoietic, lymphoid, and solid tumors (4). Mcl-1 overexpression is often associated with chemotherapeutic resistance and relapse of tumors (42, 44) , and its depletion is sufficient to promote apoptosis in cancer cells (8, 19, 36) , suggesting that Mcl-1 represents a potential therapeutic target in the treatment of a variety of human malignancies.
Apoptosis is a normal component of epithelial cell turnover in many tissues, including the gastrointestinal tract (31) . Tissue integrity is maintained when the rate of cell loss by apoptosis is matched by the rate of new cell production through proliferation. Hyperproliferation not balanced by increased levels of cell death may contribute to malignant transformation of the stomach via enhanced exposure to mutagenic substances; thus dissociation between levels of proliferation and apoptosis may 
